Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q1 2016 · 10-Q
Revenue$135.36M$135.36M+1.3% vs Q1 2015 Net Income$2.95M$2.95M+25.5% vs Q1 2015 EPS Diluted$0.11$0.11+22.2% vs Q1 2015 Gross Profit$17,977,000+26.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow-$1,765,000N/M Free Cash Flowderived-$5,252,000N/M Margins · derivedGross margin13.3%+2.7 pt vs Q1 2015
Operating margin2.9%+0.3 pt vs Q1 2015
Net margin2.2%+0.4 pt vs Q1 2015
ended Aug 30, 2015 · filed Oct 1, 2015 · 32 d after period end